Sio Capital Management as of Dec. 31, 2019
Portfolio Holdings for Sio Capital Management
Sio Capital Management holds 67 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Intra Cellular Therapies (ITCI) | 15.8 | $67M | 1.9M | 34.31 | |
| Gw Pharmaceuticals Plc ads | 4.6 | $19M | 186k | 104.56 | |
| Allergan | 4.4 | $19M | 97k | 191.17 | |
| Coherus Biosciences (CHRS) | 4.0 | $17M | 947k | 18.00 | |
| Medtronic (MDT) | 3.9 | $17M | 147k | 113.45 | |
| Hca Holdings (HCA) | 3.8 | $16M | 110k | 147.81 | |
| Merck & Co (MRK) | 3.6 | $15M | 170k | 90.95 | |
| Pfizer (PFE) | 3.5 | $15M | 381k | 39.18 | |
| WellCare Health Plans | 3.5 | $15M | 45k | 330.21 | |
| Cel Sci (CVM) | 3.3 | $14M | 1.5M | 9.15 | |
| Gilead Sciences (GILD) | 2.9 | $12M | 186k | 64.98 | |
| United Therapeutics Corporation (UTHR) | 2.8 | $12M | 133k | 88.08 | |
| Molina Healthcare (MOH) | 2.3 | $9.9M | 73k | 135.68 | |
| Immunovant (IMVT) | 2.3 | $9.8M | 615k | 15.87 | |
| GlaxoSmithKline | 2.3 | $9.6M | 205k | 46.99 | |
| AmerisourceBergen (COR) | 2.2 | $9.5M | 111k | 85.02 | |
| McKesson Corporation (MCK) | 2.2 | $9.5M | 68k | 138.31 | |
| Regeneron Pharmaceuticals (REGN) | 2.2 | $9.3M | 25k | 375.48 | |
| Anthem (ELV) | 2.2 | $9.3M | 31k | 302.03 | |
| Biotelemetry | 2.0 | $8.7M | 188k | 46.30 | |
| Sanofi-Aventis SA (SNY) | 2.0 | $8.6M | 171k | 50.20 | |
| Mei Pharma | 1.4 | $5.9M | 2.4M | 2.48 | |
| Viking Therapeutics (VKTX) | 1.4 | $5.9M | 732k | 8.02 | |
| Merit Medical Systems (MMSI) | 1.1 | $4.7M | 150k | 31.22 | |
| Ardelyx (ARDX) | 1.1 | $4.7M | 622k | 7.51 | |
| Hill-Rom Holdings | 1.1 | $4.6M | 40k | 113.53 | |
| Alnylam Pharmaceuticals (ALNY) | 1.0 | $4.2M | 37k | 115.17 | |
| Alexion Pharmaceuticals | 1.0 | $4.1M | 38k | 108.15 | |
| Arena Pharmaceuticals | 1.0 | $4.1M | 89k | 45.42 | |
| Integer Hldgs (ITGR) | 0.8 | $3.6M | 45k | 80.44 | |
| Esperion Therapeutics (ESPR) | 0.8 | $3.4M | 57k | 59.64 | |
| Syneos Health | 0.8 | $3.2M | 53k | 59.48 | |
| Syros Pharmaceuticals | 0.7 | $3.1M | 449k | 6.91 | |
| Sage Therapeutics (SAGE) | 0.7 | $3.0M | 42k | 72.20 | |
| Trillium Therapeutics, Inc. Cmn | 0.7 | $2.8M | 2.8M | 1.03 | |
| Affimed Therapeutics B V | 0.7 | $2.8M | 1.0M | 2.74 | |
| Harrow Health (HROW) | 0.6 | $2.7M | 345k | 7.78 | |
| Zafgen | 0.6 | $2.5M | 2.3M | 1.11 | |
| Pfenex | 0.6 | $2.6M | 233k | 10.98 | |
| Urovant Sciences | 0.6 | $2.5M | 160k | 15.51 | |
| Medpace Hldgs (MEDP) | 0.5 | $2.2M | 27k | 84.06 | |
| Aslan Pharmaceuticals Adr ads | 0.5 | $2.1M | 1.0M | 2.03 | |
| Radius Health | 0.5 | $2.0M | 100k | 20.16 | |
| Wave Life Sciences (WVE) | 0.4 | $1.8M | 219k | 8.01 | |
| Koninklijke Philips Electronics NV (PHG) | 0.4 | $1.6M | 34k | 48.79 | |
| Bionano Genomics | 0.3 | $1.5M | 1.2M | 1.24 | |
| Revance Therapeutics (RVNC) | 0.3 | $1.4M | 88k | 16.23 | |
| Halozyme Therapeutics (HALO) | 0.3 | $1.4M | 79k | 17.73 | |
| Catalyst Biosciences | 0.3 | $1.4M | 205k | 6.81 | |
| Aravive | 0.3 | $1.3M | 98k | 13.67 | |
| Exicure | 0.3 | $1.3M | 453k | 2.86 | |
| Atreca Inc Cl A (BCEL) | 0.3 | $1.3M | 85k | 15.47 | |
| Arvinas Ord (ARVN) | 0.3 | $1.2M | 30k | 41.10 | |
| Progyny (PGNY) | 0.3 | $1.2M | 45k | 27.45 | |
| Opko Health (OPK) | 0.3 | $1.2M | 805k | 1.47 | |
| Spectrum Pharmaceuticals | 0.3 | $1.1M | 311k | 3.64 | |
| Ovid Therapeutics (OVID) | 0.3 | $1.1M | 265k | 4.15 | |
| Neoleukin Therapeutics | 0.3 | $1.1M | 88k | 12.32 | |
| Abeona Therapeutics | 0.2 | $924k | 283k | 3.27 | |
| Mersana Therapeutics (MRSN) | 0.2 | $953k | 166k | 5.73 | |
| Logicbio Therapeutics | 0.2 | $906k | 126k | 7.20 | |
| Karuna Therapeutics Ord | 0.2 | $722k | 9.6k | 75.30 | |
| Precision Biosciences Ord | 0.1 | $603k | 43k | 13.88 | |
| Leap Therapeutics | 0.1 | $533k | 476k | 1.12 | |
| Cantel Medical | 0.1 | $518k | 7.3k | 70.96 | |
| Mettler-Toledo International (MTD) | 0.1 | $317k | 400.00 | 792.50 | |
| Aptose Biosciences | 0.1 | $284k | 50k | 5.68 |
